Abstract
Aim:
The multiplexed, microsphere-based flow cytometric assay (MFCA) for multiple human tumor markers was established for the early screening and detection of suspected cancer patients.
Methods:
Covalent coupling of capture antibodies directed against their respective tumor markers to fluorescent microspheres was performed by following the protocols recommended by a commercial corporation with some modifications. The coupling efficiency and cross-reactivity were identified by the Luminex 100 system and associated software. The standard curve was constructed by using serial dilution of recombinant tumor marker standards and was validated by comparison with ELISA for quantifying the tumor markers in serum samples.
Results:
The identifications revealed that the coupling procedures were successful without non-specific cross-reactivity and the standard curve was highly efficient. However, it was necessary to ensure the quality control of the coupling process since slight variations in the coupling procedures could profoundly affect the density of capture reagents coupled to the microspheres and consequently adversely affect the assay precision. In addition to its multi-analyte capability, the MFCA system had definite advantages, such as higher reproducibility, greater dynamic range of measurement, and considerably less preparation time and labor over the conventional “gold standard”, which was the ELISA.
Conclusion:
The successful establishment of the MFCA system for the simultaneous detection of multiple tumor markers will provide the foundation for the further study of clinical applications.
Similar content being viewed by others
Article PDF
References
Sturgeon C . Practice guidelines for tumor marker use in the clinic. Clin Chem 2002; 48: 1151–9.
Cillo U, Navaglia F, Vitale A, Molari A, Basso D, Bassanello M, et al. Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma. Clin Chim Acta 2004; 374: 129–38.
Hulse RE, Kunkler PE, Fedynyshyn JP, Kraig RP . Optimization of multiplexed bead-based cytokine immunoassays for rat serum and brain tissue. J Neurosci Method 2004; 136: 87–98.
Martins TB, Pasi BM, Litwin CM, Hill HR . Heterophile antibody interference in a multiplexed fluorescent microsphere immunoassay for quantitation of cytokines in human serum. Clin Diagn Lab Immunol 2004; 11: 325–9.
Jager W, Velthuis H, Prakken BJ, Kuis W, Rijkers GT . Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 2003; 10: 133–9.
Tarnok A, Hambsch J, Chen R, Varro R . Cytometric bead array to measure six cytokines in twenty-five microliters of serum. Clin Chem 2003; 49: 1000–2.
Jia XC, Raya R, Zhang L, Foord O, Walker WL, Gallo ML, et al. A novel method of multiplexed competitive antibody binning for the characterization of monoclonal antibodies. J Immunol Methods 2004; 288: 91–8.
Biagini RE, Sammons DL, Smith JP, MacKenzie BA, Striley CA, Semenova V, et al. Comparison of a multiplexed fluorescent covalent microsphere immunoassay and an enzyme-linked immunosorbent assay for measurement of human immunoglobulin G antibodies to anthrax toxins. Clin Diagn Lab Immunol 2004; 11: 50–5.
Khan SS, Smith MS, Reda D, Suffredini AF, McCoy JP . Multiplex bead array assays for detection of soluble cytokines: Comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytometry 2004; 61: 35–9.
Jani IV, Janossy G, Brown DW, Mandy F . Multiplexed immunoassays by flow cytometry for diagnosis and surveillance of infectious diseases in resource-poor settings. Lancet Infect Dis 2002; 2: 243–50.
Faucher S, Martel A, Sherring A, Ding T, Malloch L, Kim JE, et al. Protein bead array for the detection of HIV-1 antibodies from fresh plasma and dried-blood-spot specimens. Clin Chem 2004; 50: 1250–3.
Bellisario R, Colinas RJ, Pass KA . Simultaneous measurement of thyroxine and thyrotropin from newborn dried blood-spot specimens using a multiplexed fluorescent microsphere immunoassay. Clin Chem 2000; 46: 1422–4.
Lukacs Z, Mordac C, Kohlschutter A, Kruithof R . Use of microsphere immunoassay for simplified multianalyte screening of thyrotropin and thyroxine in dried blood spots from newborns. Clin Chem 2003; 49: 335–6.
Kellar KL, Iannone MA . Multiplexed microsphere-based flow cytometric assays. Exp Hematol 2002; 30: 1227–37.
Carson RT, Vignali DA . Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. J Immunol Methods 1999; 227: 41–52.
Wong SJ, Demarest VL, Boyle RH, Wang T, Ledizet M, Kar K, et al. Detection of human anti-flavivirus antibodies with a West Nile Virus recombinant antigen microsphere immunoassay. J Clin Microbiol 2004; 42: 65–72.
Kellar KL, Douglass JP . Multiplexed microsphere-based flow cytometric immunoassays for human cytokines. J Immunol Methods 2003; 279: 277–85.
Pataki J, Szabo M, Lantos E, Szekvolgyi L, Molnar M, Hegedus E, et al. Biological microbeads for flow-cytometric immunoassays, enzyme titrations, and quantitative PCR. Cytometry A 2005, 68: 45–52.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the Science and Technology Foundation of Guangzhou city (No 2004Z2-E0132 to Qian Wang).
Rights and permissions
About this article
Cite this article
Sun, K., Wang, Q., Huang, Xh. et al. Establishment of multiplexed, microsphere-based flow cytometric assay for multiple human tumor markers. Acta Pharmacol Sin 28, 2011–2018 (2007). https://doi.org/10.1111/j.1745-7254.2007.00673.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2007.00673.x